(2E)-3-(2,4-dimethoxyphenyl)-1-(2,4-dimethylphenyl)prop-2-en-1-one, 95.0%, 10g

N-(2-hydroxyethyl)ethylenediamine-N,N',N'-triacetic acid trisodium salt, 98%, 500g

3-(4-Chlorobenzoyl)pyridine, 95.0%, 1g

(S)-1-(4,4-Dimethylcyclohexyl)ethanamine hydrochloride, 1g

Conexión de junta esférica, 13/5, 100 mm, 10 Pieza(s)

1,4-Cyclohexanedione>98.0%(GC)500g

2-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97.0%, 25g

4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide, 98.0%, 25g

[1,1'-Biphenyl]-3,3'-dicarbonitrile, 96%, 25g

(4S,5R)-5-(Acetoxymethyl)tetrahydrofuran-2,4-diyl diacetate, 95.0%, 5g

4-Bromo-7-chloroisoquinolin-1(2H)-one, 95.0%, 250mg

[1-(6-Chloro-3-pyridyl)cyclobutyl]methanol, 95%, 100mg

(S)-1-(1-Methyl-1H-pyrazol-4-yl)ethanamine dihydrochloride, 98%, 250mg